Michael Matly

Anonymous Health is the worlds most powerful AI Suite for behavioral health providers. Our "first in world" capabilities deliver proven impact across all the metrics that support the sustainability and success of our partners and their patients: lead-to-admission conversion rates; commit-to-admit rates; length-of-service; step-down conversion rate; and alumni engagement. Our integrations to leading CRMs and EMRs allow behavioral health organizations to rapidly launch with Anonymous Health without changing their core systems.

Canopy helps hospitals ensure that healthcare workers feel safe, appreciated, and empowered every day to deliver the highest quality of care. As the leader in the Connected Safety Platform category, Canopy technology protects over 300,000 healthcare workers across more than 50 leading health systems nationwide. We provide a comprehensive, end-to-end service combining reliable wearable technology, ubiquitous coverage, intelligent alerting, and actionable insights. Canopy was founded in 2019, developing its solution in partnership with leading health systems, experienced healthcare executives, and veteran Silicon Valley entrepreneurs.

We’re coding rebels with a cause. KODE is a health-tech company seeking to break the traditional model of medical coding. Weve created the first & only on-demand platform that connects healthcare providers and coders in real-time. Get in touch with us! ➡️ info@kodehealth.com

Cherry Technologies is a fintech company helping health and wellness providers serve more people by offering top-tier payment plans with high approvals, low cost, and a seamless experience. With leading terms for practices and patients, Cherry is the preferred partner in dental, veterinary, medical aesthetics, plastic surgery and beyond.

At Codoxo, formerly Fraudscope, we’re on a mission to make our healthcare system more affordable and effective. Our Forensic AI Platform uses a patented algorithm to identify problems and suspicious behavior earlier than traditional techniques which helps ensure our scarce healthcare dollars go to real patient care. If you would like to schedule a demo, please contact sales@codoxo.com

Arine’s industry-leading software platform seamlessly integrates cutting-edge AI, clinical expertise, and advanced data analytics to deliver medication-based care interventions at the population level. Using Arine outcomes data, these proactive interventions are dynamically updated to provide a value-based solution that improves patient outcomes and reduces costs with unparalleled precision and efficiency. See how Arines medication intelligence sets a new standard in value-based care for health plans and at-risk providers.

Too many communication channels and competing requests make it harder for clinicians to focus on what’s important. TigerConnect’s unified healthcare communication solutions connect care teams across departments and beyond hospitals. As a strategic partner, we streamline clinical workflows throughout the care continuum so information can flow faster. With more efficient processes, clinicians can spend less time connecting the dots and more time delivering care.

Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1 Complications of the Zephyr Endobronchial Valve treatment can include but are not limited to pneumothorax, worsening of COPD symptoms, hemoptysis, pneumonia, dyspnea and, in rare cases, death.1 1. Criner G et al AM J Resp Crit Care Med 2018, Published on 22-May-2018 as 10.1164/rccm.201803-0590OC Brief Statement: The Pulmonx Zephyr® Endobronchial Valves are implantable bronchial valves indicated for the bronchoscopic treatment of adult patients with hyperinflation associated with severe emphysema in regions of the lung that have little to no collateral ventilation. The Zephyr Valve is contraindicated for: Patients for whom bronchoscopic procedures are contraindicated; those with evidence of active pulmonary infection; known allergies to Nitinol (nickel-titanium) or its constituent metals (nickel or titanium); known allergies to silicone, or with large bullae encompassing greater than 30% of either lung; Patients who have not quit smoking. The Zephyr Valve should be used with caution and only after careful consideration in treating patients with: Prior lung transplant, LVRS, median sternotomy, or lobectomy; Congestive heart failure or recent myocardial infarction; FEV1 <15% of predicted value. Use is restricted to a trained physician. Prior to use, please reference the Zephyr Endobronchial Valve System Instructions for more information on indications, contraindications, warnings, all precautions, and adverse events.

The world of medicine is forever evolving, with new demands and challenges around every corner. We're always looking ahead to bring tomorrow's solutions to today's providers. Some might call it foresight or innovation. We call it Tebra. Today we’re helping practices thrive with solutions for practice operations and practice growth across our two products, Kareo and PatientPop. Together, they become the complete operating system for practice success. We are Tebrans and we are building the future of well-being, together! Want to join our team? Check out our careers page.

Pure Life Renal is a dialysis company looking to partner through new clinic development or acquisition with nephrologists that want to be relevant and influential in their partnership. We provide nephrologists greater autonomy and freedom in managing their patients'​ care. We provide the business and operational management tools along with the necessary administrative structure that enable our physicians to concentrate on care in a well managed environment.

EPIRUS Biopharmaceuticals (Nasdaq:EPRS) is a pure-play biosimilar company focused on the global development and commercialization of biosimilar monoclonal antibodies (mAbs). EPIRUS' goal is to improve global patient access to important, cost-effective medicines. The company's current pipeline of biosimilar product candidates includes: BOW015 (infliximab, reference biologic Remicade®) currently marketed outside the U.S. and in an ongoing global Phase 3 study for registration in Europe and North America; BOW050 (adalimumab, reference biologic Humira®); BOW070 (tocilizumab, reference biologic Actemra®); BOW080 (eculizumab, reference biologic Soliris®); BOW090 (ustekinumab, reference biologic STELARA®); and BOW100 (golimumab, reference biologic SIMPONI®). The reference products for these candidates together generated approximately $29.2 billion in global sales for 2014, according to EvaluatePharma®. EPIRUS has established multiple partnerships to support its regulatory and commercialization efforts in global markets.

Pivot Medical is a privately held medical device company singularly focused on developing and marketing groundbreaking technologies that advance the practice of hip arthroscopy. The hip joint’s unique anatomy often makes surgical intervention complicated. So Pivot was established to address the clinical challenges facing the many hip specialists seeking ways to improve their arthroscopic techniques when treating hip patients. The company's specialization in this rapidly growing orthopedic market segment has resulted in some truly remarkable innovations in hip arthroscopy. Pivot is currently leveraging its extensive experience in orthopedics to collaborate with the world's leading sports medicine and open hip surgeons. Together, we are identifying key clinical challenges, and explore new ways to meet those challenges. Our research team continues to examine new ideas and develop advanced technologies that shorten procedure times, minimize tissue damage, and restore anatomical function. With the aid of our devices, hip surgeons are enhancing their surgical techniques and changing the lives of their patients. Surgeons can now provide minimally-invasive treatments to the countless number of hip pain patients throughout the world.

Anonymous Health is the worlds most powerful AI Suite for behavioral health providers. Our "first in world" capabilities deliver proven impact across all the metrics that support the sustainability and success of our partners and their patients: lead-to-admission conversion rates; commit-to-admit rates; length-of-service; step-down conversion rate; and alumni engagement. Our integrations to leading CRMs and EMRs allow behavioral health organizations to rapidly launch with Anonymous Health without changing their core systems.

Canopy helps hospitals ensure that healthcare workers feel safe, appreciated, and empowered every day to deliver the highest quality of care. As the leader in the Connected Safety Platform category, Canopy technology protects over 300,000 healthcare workers across more than 50 leading health systems nationwide. We provide a comprehensive, end-to-end service combining reliable wearable technology, ubiquitous coverage, intelligent alerting, and actionable insights. Canopy was founded in 2019, developing its solution in partnership with leading health systems, experienced healthcare executives, and veteran Silicon Valley entrepreneurs.

We’re coding rebels with a cause. KODE is a health-tech company seeking to break the traditional model of medical coding. Weve created the first & only on-demand platform that connects healthcare providers and coders in real-time. Get in touch with us! ➡️ info@kodehealth.com

Cherry Technologies is a fintech company helping health and wellness providers serve more people by offering top-tier payment plans with high approvals, low cost, and a seamless experience. With leading terms for practices and patients, Cherry is the preferred partner in dental, veterinary, medical aesthetics, plastic surgery and beyond.

We invest in remarkable entrepreneurs working at the intersection of healthcare and technology. We work with entrepreneurs at the earliest stages of launching and building a business - starting with thinking through the concepts that may yet become a company.